We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug & Device Products
FDAnews Books Library
Events
Form 483s Database
Publications
Webinar Training Pass
eCFR and Guidances
Books
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Frederick Razzaghi
Frederick Razzaghi
Products
PRODUCTS
Premier Trends, LLC
Adetutu Gidado
and
Frederick Razzaghi
Price:
$117.00
View
Carnegie Pharmaceuticals, LLC
Frederick Razzaghi
Price:
$117.00
View
Aurolife Pharma LLC, Inc.
Frederick Razzaghi
and
Yong Wu
Price:
$117.00
View
Aurolife Pharma LLC, Inc.
Frederick Razzaghi
and
Yong Wu
Price:
$117.00
View
Church & Dwight Co., Inc.
Frederick Razzaghi
Price:
$117.00
View
Novitium Pharma, Inc.
Frederick Razzaghi
Price:
$117.00
View
CMIC CMO USA Corp., Inc.
Frederick Razzaghi
Price:
$117.00
View
West-ward Pharmaceutical Corp.
Frederick Razzaghi
Price:
$117.00
View
Acino Products, LLC
Frederick Razzaghi
Price:
$117.00
View
Liberty Drug & Surgical
Susan Hadman
,
Philip F. Istafanos
,
Frederick Razzaghi
,
Nicholas A. Violand
, and
Barbara J. Wilimczyk-Macri
Price:
$117.00
View
View All Products by Frederick Razzaghi
Upcoming Events
13
Jul
FDA Ad and Promo Enforcement Trends: Past, Present and Future
27
Jul
Applying the Lessons of the Pandemic to Your Upcoming Trial
28
Jul
EU-MDR’s Growing Pains: Are You Current with the Latest Developments?
02
Aug
Medical Device Cybersecurity: Understand the Latest Developments
03
Aug
Pharmaceutical Process Validation: Best Practices for Success
10
Aug
Gene & Cell Therapy Regulation: Comparability and Other New Developments
Featured Products
FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485
Selecting and Implementing Electronic Document Management Systems in the EU
Featured Stories
FDA Approves Foundation Medicine’s Companion Diagnostic for Genentech’s Rozlytrek
Novartis Pays $100 Million for Mallinckrodt’s Priority Review Voucher
FDA Approves Beyond Air’s LungFit PH for Newborn Pulmonary Hypertension
FDA Grants Priority Review to Roche’s Lunsumio for Follicular Lymphoma
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
